Related Content
One of the big advancements in drug-eluting stent (DES) technology has been the development of bioresorbable polymers ...
December 13, 2016 β Biotronik announced the presentation of data confirming the efficacy of the Pulsar-18 bare metal ...
November 9, 2016 β Results from a randomized, multicenter trial failed to show non-inferiority of hybrid, ultra-thin ...
September 27, 2016 β In August, the European Heart Rhythm Association (EHRA) and EP Europace journal announced the ...
June 28, 2016 β A recent report published by Allied Market Research, titled, "Congestive Heart Failure (CHF) Treatment ...
June 23, 2016 β Biotronik announced it was the winner of the Cardiostim Innovation Award in the category βBest Practice ...
June 3, 2016 β Biotronik announced results establishing non-inferiority of the Orsiro hybrid drug-eluting stent (DES) to ...
June 1, 2016 β Biotronik announced the launch of CardioMessenger Smart in the United States. CardioMessenger Smart is a ...
May 17, 2016 β Biotronik presented 12-month data from the BIOSOLVE-II trial during a Hotline Session at EuroPCR 2016 ...
May 3, 2016 β Biotronik announced U.S. Food and Drug Administration (FDA) approval of Iperia ProMRI HF-T, a cardiac ...